NICE has published new guidelines on the management of patients with severe asthma, pneumonia, rheumatological autoimmune, inflammatory and metabolic bone disorders and the management of COVID-19 symptoms in the community.
The Government is calling on pharmaceutical giants and diagnostic companies to join forces on plans to roll out millions of coronavirus (COVID-19) tests.
Twenty of Althea’s specialist biomed engineers are playing a vital role at the newly built Nightingale NHS Hospital in London to build, test and commission thousands of lifesaving medical equipment ready for the first patients to be treated.
Harrogate Nightingale to implement Silverlink PAS to support staff and patients amid Coronavirus pandemic
The new Nightingale Hospital set to open at Harrogate Convention Centre to support the increasing number of patients with Covid-19, will be underpinned a leading Patient Administration Systems (PAS), designed specifically for the NHS.
As the UK faces a shortage of protective equipment in hospitals due to the ongoing crisis surrounding COVID-19, IBM staff with 3D printers are turning their devices and skills to helping alleviate the shortage by producing them themselves after an internal rallying call for expertise and supplies.
Amid the potential acute shortages of ventilators at the peak of the COVID-19 pandemic, researchers have shown in a new simulation study the potential for ventilators to be manipulated to ventilate two patients independently.
Managed service and maintenance provider Althea is urging UK hospitals who have disused ventilation equipment to contact them immediately.
The use of robotics and artificial intelligence has been a key feature in the fight against Coronavirus in China, where the technology has been used for infection control, logistical tasks and support in the treatment of patients. Now a British-based organisation, MedAssyst, is bringing the technology to the UK.
The world’s largest randomised clinical trial of potential coronavirus treatments is underway in the UK as part of the race to find a treatment.
A survey of over 2,513 members of the Royal College of Physicians (RCP) has revealed that only 31% of its members are able to access COVID-19 testing for themselves if they have symptoms.
The new NICE guidelines cover the provision of radiotherapy services and bone marrow transplant during the COVID-19 pandemic.
Innovate UK, part of UK Research and Innovation (UKRI), is working closely with Formula 1 and a collective of UK-based teams, engine manufacturers and their respective technology arms as part of Project Pitlane to co-ordinate work in scaling up ventilator production for patients with coronavirus.
A new project has been launched to unite engineers from across the world to help solve challenges deriving from the Covid-19 pandemic.
The Government and the UK’s Chief Scientific Adviser have backed UK clinicians and scientists to map how COVID-19 spreads and behaves by using whole genome sequencing.
Engineers and medical staff from the University of Southampton are testing a prototype of a personal respirator they have developed for frontline healthcare staff tackling the COVID-19 pandemic. If the tests are successful, they hope it will solve the limitations of existing protective equipment doctors and nurses are wearing on the wards.
A team of scientists at the University of Southampton have announced a trial of an inhaled drug that may help people reduce the symptoms of COVID-19. This trial is being supported by the NIHR through its Respiratory Translational Research Collaboration (R-TRC).
A Continuous Positive Airway Pressure (CPAP) device could provide an alternative breathing aid to help COVID-19 patients with serious lung infections, without the need to use invasive ventilators – according a team of engineers and clinicians, from Formula 1 and UCLH.
Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according to a new editorial published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.